AU2019900345A0 - An anti-cell-senescence composition and method of use - Google Patents

An anti-cell-senescence composition and method of use

Info

Publication number
AU2019900345A0
AU2019900345A0 AU2019900345A AU2019900345A AU2019900345A0 AU 2019900345 A0 AU2019900345 A0 AU 2019900345A0 AU 2019900345 A AU2019900345 A AU 2019900345A AU 2019900345 A AU2019900345 A AU 2019900345A AU 2019900345 A0 AU2019900345 A0 AU 2019900345A0
Authority
AU
Australia
Prior art keywords
senescence
cell
composition
senescence composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019900345A
Inventor
Raymond Denis PALMER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helium 3 Biotech Pty Ltd
Original Assignee
Helium 3 Biotech Pty Ltd
Filing date
Publication date
Application filed by Helium 3 Biotech Pty Ltd filed Critical Helium 3 Biotech Pty Ltd
Publication of AU2019900345A0 publication Critical patent/AU2019900345A0/en
Priority to PCT/AU2020/050093 priority Critical patent/WO2020160618A1/en
Abandoned legal-status Critical Current

Links

AU2019900345A 2019-02-05 2019-02-05 An anti-cell-senescence composition and method of use Abandoned AU2019900345A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2020/050093 WO2020160618A1 (en) 2019-02-05 2020-02-05 An anti-cell-senescence composition and method of use

Publications (1)

Publication Number Publication Date
AU2019900345A0 true AU2019900345A0 (en) 2019-02-21

Family

ID=

Similar Documents

Publication Publication Date Title
EP3962296A4 (en) Cannabinoid compositions and methods of using
EP3749343A4 (en) Formulation and method of use
EP3962479A4 (en) Kcnt1 inhibitors and methods of use
EP3962481A4 (en) Kcnt1 inhibitors and methods of use
EP3983386A4 (en) Acss2 inhibitors and methods of use thereof
EP3829307A4 (en) Bismuth-thiol compositions and methods of use
EP3986894A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP3856214A4 (en) Microbial compositions and methods of use
EP3980043A4 (en) Thermogelling cannabinoid composition and method of manufacture and use thereof
EP3983809A4 (en) Biothiol-activatable probe and method of use
EP3952721A4 (en) Endoscope and method of use
EP3786156A4 (en) 10h-phenothiazine ferroptosis inhibitor and preparation method therefor and application thereof
EP4005561A4 (en) Nano-micelle preparation of icaritin and preparation method therefor and application thereof
EP3959197A4 (en) Papd5 inhibitors and methods of use thereof
EP3969460A4 (en) Ascaroside derivatives and methods of use
EP3934426A4 (en) Preservative compositions and methods of use thereof
EP3761969A4 (en) Cooling composition and method of use
EP3986488A4 (en) Adhesive composition and method of making and using the same
EP3941909A4 (en) Pi4-kinase inhibitors and methods of using the same
EP3793552A4 (en) Abhd12 inhibitors and methods of making and using same
EP4081233A4 (en) Composition and methods of manufacture
EP4054514A4 (en) Compositions containing fenchols and methods of use
EP4034099A4 (en) Pimobendan formulation and method of use thereof
EP4007497A4 (en) ß-ARRESTIN-MODULATING COMPOUNDS AND METHODS OF USING SAME
AU2020327592A1 (en) Sprayable composition and method